Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors
ATLANTA, Aug. 9, 2023 /PRNewswire/ -- Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the administration, transport and storage of drugs and vaccines, today announced the appointment of drug delivery and healthcare innovation veteran, Brian Bernick, MD, as Chairman of the company's Board of Directors.
- ATLANTA, Aug. 9, 2023 /PRNewswire/ -- Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the administration, transport and storage of drugs and vaccines, today announced the appointment of drug delivery and healthcare innovation veteran, Brian Bernick, MD, as Chairman of the company's Board of Directors.
- "Dr. Brian Bernick has a long-standing record of patient-centered innovation and a unique perspective as both an internationally recognized OBGYN and an entrepreneur bringing self-administered drug delivery innovations to market," said Steven Damon, CEO of Micron Biomedical.
- "Traditionally, injectable therapeutics and vaccines can be inaccessible to many patients in low to middle-income as well as high-income geographies due to access to healthcare services and patient and caregiver hesitation about needles," said Dr. Brian Bernick, Chairman of the Board of Directors at Micron Biomedical.
- The appointment follows the company's recent release of positive data from the first clinical trial of any microarray technology in pediatric populations.